Trying to separate three different claims about BPC-157: that it is the right molecule, that it is the right dose, and that it does something useful.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Mechanism is not outcome, and a plausible pathway is the most expensive kind of evidence there is.
What the peptide class does pharmacologically does not require the subjective effect to be large to be real.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
How do you separate the compound effect from the routine around it?
Nobody has ever been talked out of a stack by a stranger on the internet.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
Stupid question: how do you know whether what is in the vial matches the label at all?
Baseline first.
This board overrates bloodwork. A number moving is not the outcome you wanted.